JenniferYWoMD

Radiation Oncology • Boston, MA

Associate Professor in Radiation Oncology, Massachusetts General Hospital

Join to view full profile

Dr. Wo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wo's full profile

Already have an account?

Office
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone+1 617-726-6050

Fax+1 617-726-3603

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2006 - 2010
Mount Auburn HospitalInternship, Internal Medicine, 2005 - 2006
Columbia University Vagelos College of Physicians and SurgeonsClass of 2005

Certifications & Licensure

MA State Medical License 2007 - 2026
ME State Medical License Active through 2025
NH State Medical License 2021 - 2025
RI State Medical License 2020 - 2024
American Board of Radiology Radiation Oncology

Clinical Trials

Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma Start of enrollment: 2013 Jul 01
Active, not recruiting
Early Phase 1

Publications & Presentations

PubMed

43 citations
Impact of Postoperative Complication and Completion of Multimodality Therapy on Survival in Patients Undergoing Gastrectomy for Advanced Gastric Cancer.
Selena S. Li, Brooks V. Udelsman, Aparna Raj Parikh, Samuel J. Klempner, Jeffrey W. Clark
Journal of the American College of Surgeons. 2020-06-01
122 citations
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial
Aparna Raj Parikh, Annamaria Szabolcs, Jill N. Allen, Jeffrey W. Clark, Jennifer Y. Wo
Nature Cancer. 2021-11-01
95 citations
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma
Darrell R. Borger, Lipika Goyal, Thomas Yau, Ronnie T.P. Poon, Marek Ancukiewicz
Clinical Cancer Research. 2014-04-01

Journal Articles

Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer
Harvey J Mamon, Paul L Nguyen, Theodore S Hong, Aparna Parikh, Jennifer Y Wo, Rinaa S Punglia, Cristina Ferrone, Ryan D Nipp, Annals of Surgical Oncology

Lectures

A pilot study of neoadjuvant FOLFIRINOX followed by chemoradiation for gastric and gastroesophageal cancer: Preliminary results.
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

Practice Change: Transform Cancer Care Through Quality Improvement and Evidence-Based PracticeOctober 5th, 2021
Trial: Gains Seen on Inoperable Pancreatic CancerMay 30th, 2019
UCLA Researchers Study Cost-Effectiveness of Rectal Cancer TreatmentsApril 17th, 2019
Join now to see all